KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deffered Revenue (2016 - 2025)

Idexx Laboratories has reported Non-Current Deffered Revenue over the past 17 years, most recently at $32.2 million for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $32.2 million for Q4 2025, up 19.44% from a year ago — trailing twelve months through Dec 2025 was $32.2 million (up 19.44% YoY), and the annual figure for FY2025 was $32.2 million, up 19.44%.
  • Non-Current Deffered Revenue for Q4 2025 was $32.2 million at Idexx Laboratories, up from $31.1 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for IDXX hit a ceiling of $44.2 million in Q1 2021 and a floor of $26.8 million in Q3 2024.
  • Median Non-Current Deffered Revenue over the past 5 years was $31.0 million (2022), compared with a mean of $32.8 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: decreased 25.22% in 2021 and later rose 19.44% in 2025.
  • Idexx Laboratories' Non-Current Deffered Revenue stood at $41.2 million in 2021, then dropped by 25.04% to $30.9 million in 2022, then fell by 7.55% to $28.5 million in 2023, then dropped by 5.59% to $26.9 million in 2024, then increased by 19.44% to $32.2 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $32.2 million (Q4 2025), $31.1 million (Q3 2025), and $31.8 million (Q2 2025) per Business Quant data.